Tatva Chintan Pharma IPO Details

Upcoming IPO

Tatva Chintan Pharma Chem is established in 1996 by Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Snehkar Rasiklal Somani are the company promoters.

Tatva Chintan Pharma Chem Limited produces structure directing agents (SDAs), phase transfer catalysts (PTCs), pharmaceutical and agricultural intermediates, and other speciality chemicals. It is one of India’s leading manufacturers of SDAs for zeolites. Automotive, petroleum, agrochemicals, dyes & pigments, paints and coatings, pharmaceutical, personal care, and other industries are served by the company. Its products are sold not just in India, but also in more than 25 countries throughout the world, including the United States, Germany, South Africa, China, and the United Kingdom. Total export provided 76 percent of total revenue from operations in FY 2020.

Check :- IPO Allotment Status

Among the company’s customers are Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi’s laboratories. It currently operates two manufacturing sites in Gujarat: Ankleshwar and Dahej.We have shared the details of tatva chintan pharma ipo and grey market premium gmp.

Competitive advantages

  • Structure directing agents and phase transfer catalysts from a leading company.
  • Product portfolio with a wide range of options.
  • With a customer base spanning multiple industries, we have a global market presence.
  • A industrial complex in Gujarat that is strategically placed near the Hazira Port.
  • Team of seasoned promoters and managers.
  • A proven track record of financial success.
    • Tatva Chintan Pharma IPO details
    Subscription Dates 16-20 July 2021
    Price Band 1073-1083 Rs Per Share
    Offer For Sale 275 crore
    Fresh issue 225 crore
    Total IPO size 500 crore
    Minimum bid (lot size) 13 Rs Share
    Face Value 10 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Tatva Chintan Pharma Market Lot
    Lot No of Shares Amount
    Minimum 1 13 Shares 14,079 Rs
    Maximum 14 182 Shares 1,97,106 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Mar-21
    Total Assets : 3,148.03
    Total Revenue : 3,062.92
    Profit After Tax : 522.62
    Earnings Per Share (EPS) FY2021 : 18.81 Rs

    Registrar of Tatva Chintan IPO

    Link Intime India Private Limited
    C-101, 1st Floor, 247 Park
    Lal Bahadur Shastri Marg,
    Vikhroli (West) Mumbai – 400 083
    Phone: +91 22 4918 6200
    Fax: +91 22 4918 6195
    Website: http://www.linkintime.co.in

    Tatva Chintan Contact Details

    Tatva Chintan Pharma Chem Limited
    Plot No. 353, Makarpura GIDC,
    Vadodara, Gujarat – 390 010
    Phone: +91 75748 48533
    Email: [email protected]
    Website: www.tatvachintan.com

    Leave a Reply